Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
Mona O. Mohsen, Dominik A. Rothen, Ina Baļķe, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Virus-like particle vaccinology, from bench to bedside
Mona O. Mohsen, Martin F. Bachmann
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 993-1011
Open Access | Times Cited: 142
Biological Nanoparticles in Vaccine Development
Stephanie M. Curley, David Putnam
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 41
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
Mona O. Mohsen, Ina Baļķe, Simon Zinkhan, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 243-257
Open Access | Times Cited: 43
The next generation virus‐like particle platform for the treatment of peanut allergy
Jan M. Sobczak, Pascal S. Krenger, Federico Storni, et al.
Allergy (2023) Vol. 78, Iss. 7, pp. 1980-1996
Open Access | Times Cited: 18
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
Dominik A. Rothen, Pascal S. Krenger, Aleksandra Nonic, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2446-2458
Open Access | Times Cited: 24
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
Anne‐Cathrine S. Vogt, Lukas Jörg, B Martina, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection
Santa-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, et al.
Nanomedicine Nanotechnology Biology and Medicine (2022) Vol. 44, pp. 102584-102584
Open Access | Times Cited: 10
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
Jan M. Sobczak, Irena Barkovska, Ina Baļķe, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 661-661
Open Access | Times Cited: 1
In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma
Mona O. Mohsen, Matthew D. Heath, Matthias Krämer, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004643-e004643
Open Access | Times Cited: 8
Viricidal Activity of Thermoplastic Polyurethane Materials with Silver Nanoparticles
Rocío Díaz‐Puertas, Enrique Fernández Rodríguez, Melissa Belló-Pérez, et al.
Nanomaterials (2023) Vol. 13, Iss. 9, pp. 1467-1467
Open Access | Times Cited: 4
Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles
Xinyue Chang, Xuelan Liu, Mona O. Mohsen, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 307-307
Open Access | Times Cited: 6
Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens
Anete Ogrina, Ina Baļķe, Ieva Kalnciema, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies
Anne‐Cathrine S. Vogt, Lukas Jörg, B Martina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Page 1

Scroll to top